Literature DB >> 25218283

R-spondin1 arguments hepatic fibrogenesis in vivo and in vitro.

Yin Xinguang1, Yi Huixing2, Wen Xiaowei3, Wu Xiaojun1, Yu Linghua4.   

Abstract

BACKGROUND: The development of liver fibrosis is the key stage toward a number of mortal complications of liver diseases, including cirrhosis and hepatocellular carcinoma. Canonical Wnt pathway is crucial in diverse biological processes and mediates the progression and regression of liver fibrosis. As a potent Wnt pathway agonist, roof plate-specific spondin-1 (R-spondin1) protein's role in the hepatic fibrosis has not been well elucidated. The purpose of this study was to investigate whether R-spondin1 contributed to hepatic stellate cells (HSC) activation, the key event in liver fibrogenesis.
MATERIALS AND METHODS: Tissue microarrays of human fibrotic liver samples, hepatocellular carcinoma samples, and normal hepatic tissue samples were constructed and immunostained for R-spondin1. Protein expression and transcriptional level of freshly isolated mice HSC were analyzed by Western blot assay and real-time polymerase chain reaction, respectively. Exogenous stimulation with recombinant R-spondin1 and Dickkopf-1 was performed to investigate the functionality. Nuclear β-catenin level and T-cell specific transcription factor activity were analyzed, and HSC proliferation was tested by Methyl-Thiazol-Tetrazolium bromide assay.
RESULTS: Overexpression of R-spondin1 was observed in both fibrotic liver tissues and culture-activated HSC. Coculture with recombinant R-spondin1 induced a dose-dependent increase in both the transcription factor activity and the protein level of α-smooth muscle actin, collagen I, and nuclear β-catenin. Additionally, Dickkopf-1 repressed R-spondin1's effect on HSC.
CONCLUSIONS: These findings suggested that R-spondin1 might argument liver fibrogenesis by enhancing the canonical Wnt pathway.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  HSC; Liver fibrosis; Nuclear β-catenin; R-spondin1; TCF; Wnt pathway

Mesh:

Substances:

Year:  2014        PMID: 25218283     DOI: 10.1016/j.jss.2014.08.009

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  6 in total

1.  Beneficial effects of LRP6-CRISPR on prevention of alcohol-related liver injury surpassed fecal microbiota transplant in a rat model.

Authors:  Linghua Yu; Linlin Wang; Huixing Yi; Xiaojun Wu
Journal:  Gut Microbes       Date:  2020-03-13

2.  Immunohistochemical Analysis of the Stem Cell Marker LGR5 in Pediatric Liver Disease.

Authors:  Zahida Khan; Anne Orr; George K Michalopoulos; Sarangarajan Ranganathan
Journal:  Pediatr Dev Pathol       Date:  2017 Jan-Feb

3.  R-spondin 2 promotes proliferation and migration via the Wnt/β-catenin pathway in human hepatocellular carcinoma.

Authors:  Xinguang Yin; Huixing Yi; Linlin Wang; Wanxin Wu; Xiaojun Wu; Linghua Yu
Journal:  Oncol Lett       Date:  2017-06-07       Impact factor: 2.967

Review 4.  R-spondin signaling as a pivotal regulator of tissue development and homeostasis.

Authors:  Kenichi Nagano
Journal:  Jpn Dent Sci Rev       Date:  2019-04-22

5.  Targeting the Wnt signaling pathway through R-spondin 3 identifies an anti-fibrosis treatment strategy for multiple organs.

Authors:  Mingjun Zhang; Michael Haughey; Nai-Yu Wang; Kate Blease; Ann M Kapoun; Suzana Couto; Igor Belka; Timothy Hoey; Matthew Groza; James Hartke; Brydon Bennett; Jennifer Cain; Austin Gurney; Brent Benish; Paola Castiglioni; Clifton Drew; Jean Lachowicz; Leon Carayannopoulos; Steven D Nathan; Jorg Distler; David A Brenner; Kandasamy Hariharan; Ho Cho; Weilin Xie
Journal:  PLoS One       Date:  2020-03-11       Impact factor: 3.240

6.  HGF/R-spondin1 rescues liver dysfunction through the induction of Lgr5+ liver stem cells.

Authors:  Yuan Lin; Zhe-Ping Fang; Hong-Juan Liu; Li-Jing Wang; Zhiqiang Cheng; Na Tang; Tingting Li; Tengfei Liu; Hai-Xiong Han; Guangwen Cao; Li Liang; Yan-Qing Ding; Wei-Jie Zhou
Journal:  Nat Commun       Date:  2017-10-27       Impact factor: 14.919

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.